ESC 365 - Doctor Mario Galvan Ruiz

Speaker illustration

Doctor Mario Galvan Ruiz

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

Member of:

Heart Failure Association

Prognosis changes in patients with transthyretin cardiac amyloidosis after attr-act study.

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters in chronic heart failure - epidemiology, prognosis, outcome 2

Prognosis value of cardiac biomarkers in transthyretin deposition cardiac amyloidosis in real life

Event: Heart Failure 2023

Topic: Biomarkers

Session: Chronic heart Failure - biomarkers 3

Use of 99mTc-DPD scan in the clinical suspicion of cardiac transthyretin amyloidosis

Event: Heart Failure 2021

Topic: Diagnostic Methods

Session: ePoster session

Experience of using sacubitril - valsartan in dialysis patients

Event: Heart Failure 2021

Topic: Pharmacotherapy

Session: ePoster session

Use of sacubitril-valsartan in elderly patients. Subanalysis of the SAVE-RLife study

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Early left ventricular reverse remodeling after sacubitril-valsartan treatment. Subanalysis of SAVE-RLife study

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Onset of sacubitril-valsartan in hospitalized vs ambulatory patients with heart failure with reduced ejection fraction in real life

Event: Acute Cardiovascular Care 2019

Topic: Pharmacotherapy

Session: Moderated Poster 5: Acute heart failure

Acute heart failure: are men and women different? Data from RECANIC study

Event: Acute Cardiovascular Care 2019

Topic: Clinical

Session: Acute Heart Failure - Clinical

RECANIC: canarian registry of patients with acute heart Failure

Event: Acute Cardiovascular Care 2019

Topic: Clinical

Session: Acute Heart Failure - Clinical

Early experience with sacubitril/valsartan in real life: impact in emergency room and hospital admissions among frequent flyers patients

Event: Heart Failure 2018

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources